Posted in | News | Nanobusiness

Thermo Fisher To Construct State-of-the-Art BioCenter for the Manufacture of Single Use Bioprocess Containers

Thermo Fisher Scientific , the world leader in serving science, today announced its plan to construct an $11 million, state-of-the-art BioCenter for the manufacture of single-use bioprocess containers (BPCs) and related products at the site of its existing bioprocess production business unit in Logan, Utah.

The BioCenter investment is a response to the increasing demand for disposable bioprocessing technology among customers in the life-sciences research, biotechnology and pharmaceutical industries. Bioprocess containers serve cell-culture applications as well as the production of protein-based drugs, and are used in mixing, storage and transportation of bioprocessing fluids and for bioreactors (used to grow cells, proteins and other biochemically active substances). Single-use bioprocessing components eliminate the risk of batch-to-batch cross contamination and significantly reduce startup costs for customers.

"We are excited about the expanded capabilities that our BioCenter will provide," said Marc N. Casper, executive vice president of Thermo Fisher Scientific. "The market outlook for the bioprocessing industry continues to be very bright as there are thousands of biotech products under development. This investment will allow us to better meet the needs of our customers as they work toward new therapies for treating disease and improving health."

The 37,000-square-foot facility is expected to be complete by the fall of 2008. It is the first of a three-phase construction plan that will create a 94,000-square-foot BioCenter over the next four years, replacing and expanding an older BPC operation in Logan. The new operation will include an administration building, sera and liquid-media processing facility, powdered- media facility, warehouse and the existing BPC facility. The initial project is expected to create 75 new jobs, both in production and management functions.

Products to be manufactured in the new facility include the Thermo Scientific HyClone BPC line - ranging from simple bioprocess containers, to complex bioprocessing systems and custom-designed units for a variety of applications. This offering includes sterile fluid-handling bags, bag manifold systems, tank liners, chambers, biopharmaceutical tubing and other accessories, as well as the recently introduced Thermo Scientific HyClone Single-Use Bioreactor (S.U.B.) and Single-Use Mixer (S.U.M.).

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.